Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04668976Phase 2Unknown
Phase 2, open-label, single-arm trial in colorectal cancer (CRC) and cholangiocarcinoma (CCA), sponsored by Benaroya Research Institute. Primary endpoints: Number of patients requiring stent replacements at 1 year and Percent frequency liver toxicity at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04668976.